newsfilter
← Latest News
PR Newswire·

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported...